Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.06B |
| 2 |
Amazon
AMZN
|
+$1.51B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.42B |
| 4 |
Tesla
TSLA
|
+$1.17B |
| 5 |
Microsoft
MSFT
|
+$997M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SJR
Shaw Communications Inc.
SJR
|
+$925M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$724M |
| 3 |
Eaton
ETN
|
+$581M |
| 4 |
Uber
UBER
|
+$538M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$510M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.98% |
| 2 | Healthcare | 10.48% |
| 3 | Financials | 9.86% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Industrials | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5226
Wave Life Sciences
WVE
$1.13B
| $355K | ﹤0.01% |
97,507
-233,957
| -71% | -$945K |
|
5227
Granite Ridge Resources
GRNT
$632M
| $354K | ﹤0.01% |
53,398
-9,408
| -15% | -$56.5K |
|
|
NB
5228
NioCorp Developments
NB
$649M
| $353K | ﹤0.01% |
70,189
+68,692
| +4,589% | +$392K |
|
|
KG
5229
Kestrel Group
KG
$66.7M
| $352K | ﹤0.01% |
8,370
-3,832
| -31% | -$164K |
|
|
THRN
5230
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $351K | ﹤0.01% |
74,785
+30,426
| +69% | +$140K |
|
5231
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
$326M
| $351K | ﹤0.01% |
14,887
+207
| +1% | +$4.94K |
|
5232
iShares International Small Cap Equity Factor ETF
ISCF
$664M
| $351K | ﹤0.01% |
11,362
-1,451
| -11% | -$45.1K |
|
5233
AirSculpt Technologies
AIRS
$344M
| $350K | ﹤0.01% |
40,661
+1,251
| +3% | +$8.18K |
|
5234
Outlook Therapeutics
OTLK
$171M
| $350K | ﹤0.01% |
10,060
+2,024
| +25% | +$55.2K |
|
5235
Monte Rosa Therapeutics
GLUE
$1.3B
| $350K | ﹤0.01% |
51,080
+12,850
| +34% | +$83.1K |
|
|
OPTN
5236
DELISTED
OptiNose
OPTN
| $350K | ﹤0.01% |
18,956
+6,408
| +51% | +$152K |
|
5237
Nuveen Short-Term REIT ETF
NURE
$36M
| $350K | ﹤0.01% |
11,493
+565
| +5% | +$16.9K |
|
5238
Park-Ohio Holdings
PKOH
$581M
| $349K | ﹤0.01% |
18,388
-1,905
| -9% | -$29K |
|
5239
Caledonia Mining Corp
CMCL
$363M
| $347K | ﹤0.01% |
29,876
-3,168
| -10% | -$44.4K |
|
|
DCFC
5240
DELISTED
Tritium DCFC Limited Ordinary Shares
DCFC
| $346K | ﹤0.01% |
1,585
+293
| +23% | +$63.6K |
|
5241
BayCom
BCML
$333M
| $344K | ﹤0.01% |
20,603
-2,769
| -12% | -$45.7K |
|
|
VRAY
5242
DELISTED
ViewRay, Inc.
VRAY
| $343K | ﹤0.01% |
974,260
+371,700
| +62% | +$385K |
|
|
RDNW
5243
RideNow Group
RDNW
$264M
| $343K | ﹤0.01% |
27,748
+4,680
| +20% | +$43.7K |
|
5244
Stratus Properties
STRS
$157M
| $343K | ﹤0.01% |
13,065
+1,560
| +14% | +$35.3K |
|
5245
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$290M
| $343K | ﹤0.01% |
10,000
+3,160
| +46% | +$108K |
|
5246
Akebia Therapeutics
AKBA
$351M
| $343K | ﹤0.01% |
374,624
-269,493
| -42% | -$260K |
|
5247
PDS Biotechnology
PDSB
$40M
| $338K | ﹤0.01% |
67,271
-36,589
| -35% | -$240K |
|
5248
Chicago Rivet & Machine Co
CVR
$10.1M
| $338K | ﹤0.01% |
13,146
-145
| -1% | -$3.87K |
|
5249
Bakkt Inc
BKKT
$329M
| $337K | ﹤0.01% |
10,963
+3,303
| +43% | +$116K |
|
|
LONA
5250
LeonaBio Inc
LONA
$70.2M
| $337K | ﹤0.01% |
11,418
-20,720
| -64% | -$590K |
|
Similar funds
Morgan Stanley's Q2 2023 Portfolio in Review
As of Q2 2023, Morgan Stanley held 7,861 positions worth $1.01T, up 8.8% from $933B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 4.8%. Morgan Stanley opened 173 new positions and exited 203, leaving the 7,861-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 3,490,516 shares worth $87.1M.
- Morgan Stanley added most to NVIDIA in Q2 2023, an estimated $2.06B increase.
- Morgan Stanley's biggest Q2 2023 reduction was iShares MSCI ACWI ETF, cutting an estimated $724M.
- Morgan Stanley fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $925M.
- Morgan Stanley's ten largest holdings make up 18% of its $1.01T portfolio in Q2 2023.
- Morgan Stanley opened 173 new positions and closed 203 in Q2 2023.
- Morgan Stanley's portfolio value rose 8.8% quarter-over-quarter to $1.01T.
Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.